Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details)

v3.24.1
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details) - USD ($)
 1 Months Ended 12 Months Ended
Oct. 31, 2023
Aug. 31, 2023
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]          
Net revenue       $ 117,059,000 $ 138,826,000
Direct operating costs       70,817,000 84,434,000
Selling and marketing       9,650,000 9,788,000
General and administrative       21,464,000 23,820,000
Research and development       4,736,000 4,401,000
Change in contingent consideration       (3,090,000)
Depreciation and amortization       14,402,000 11,725,000
Goodwill impairment charges   $ 0   42,000,000
Loss on lease terminations, unoccupied lease charges and restructuring costs       1,105,000 1,138,000
Total operating expenses       164,174,000 132,216,000
OPERATING (LOSS) INCOME       (47,115,000) 6,610,000
Healthcare IT [Member]          
Segment Reporting Information [Line Items]          
Net revenue       103,683,000 125,276,000
Direct operating costs       60,319,000 73,702,000
Selling and marketing       9,614,000 9,760,000
General and administrative       10,992,000 12,558,000
Research and development       4,736,000 4,401,000
Change in contingent consideration         (3,090,000)
Depreciation and amortization       14,046,000 11,368,000
Goodwill impairment charges $ 2,000,000.0   $ 40,000,000.0 42,000,000  
Loss on lease terminations, unoccupied lease charges and restructuring costs       1,105,000 1,138,000
Total operating expenses       142,812,000 109,837,000
OPERATING (LOSS) INCOME       (39,129,000) 15,439,000
Medical Practice Management [Member]          
Segment Reporting Information [Line Items]          
Net revenue       13,376,000 13,550,000
Direct operating costs       10,498,000 10,732,000
Selling and marketing       36,000 28,000
General and administrative       1,854,000 1,802,000
Research and development      
Change in contingent consideration        
Depreciation and amortization       356,000 357,000
Goodwill impairment charges        
Loss on lease terminations, unoccupied lease charges and restructuring costs      
Total operating expenses       12,744,000 12,919,000
OPERATING (LOSS) INCOME       632,000 631,000
Unallocated Corporate Expenses [Member]          
Segment Reporting Information [Line Items]          
Net revenue      
Direct operating costs      
Selling and marketing      
General and administrative       8,618,000 9,460,000
Research and development      
Change in contingent consideration        
Depreciation and amortization      
Goodwill impairment charges        
Loss on lease terminations, unoccupied lease charges and restructuring costs      
Total operating expenses       8,618,000 9,460,000
OPERATING (LOSS) INCOME       $ (8,618,000) $ (9,460,000)